SMITH, ANDREW
 Distribuzione geografica
Continente #
NA - Nord America 7.486
EU - Europa 4.768
AS - Asia 2.087
SA - Sud America 37
AF - Africa 16
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.405
Nazione #
US - Stati Uniti d'America 7.365
IT - Italia 1.610
CN - Cina 736
DE - Germania 717
SG - Singapore 653
IE - Irlanda 631
SE - Svezia 503
RU - Federazione Russa 337
HK - Hong Kong 317
GB - Regno Unito 210
AT - Austria 209
UA - Ucraina 147
VN - Vietnam 132
CA - Canada 106
FR - Francia 90
DK - Danimarca 80
FI - Finlandia 61
IN - India 60
ID - Indonesia 54
NL - Olanda 39
TR - Turchia 39
BR - Brasile 28
BE - Belgio 22
JP - Giappone 20
CH - Svizzera 14
ES - Italia 14
KR - Corea 14
TW - Taiwan 14
CZ - Repubblica Ceca 13
PL - Polonia 12
IR - Iran 11
MX - Messico 11
GR - Grecia 10
NO - Norvegia 9
RO - Romania 9
AU - Australia 8
HR - Croazia 7
TH - Thailandia 7
EG - Egitto 6
IL - Israele 6
LT - Lituania 5
MY - Malesia 5
PH - Filippine 5
PT - Portogallo 5
EC - Ecuador 4
BG - Bulgaria 3
DZ - Algeria 3
HU - Ungheria 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
KZ - Kazakistan 2
LV - Lettonia 2
MA - Marocco 2
PE - Perù 2
PK - Pakistan 2
SA - Arabia Saudita 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AR - Argentina 1
AZ - Azerbaigian 1
BT - Bhutan 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
EU - Europa 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
UZ - Uzbekistan 1
VG - Isole Vergini Britanniche 1
Totale 14.405
Città #
Ann Arbor 1.696
Dublin 617
Fairfield 582
Chandler 581
Milan 576
Singapore 560
Frankfurt am Main 528
Wilmington 455
Ashburn 402
Woodbridge 365
Houston 311
Hong Kong 305
Dearborn 301
Santa Clara 261
New York 253
Seattle 248
Vienna 195
Princeton 188
Cambridge 184
Jacksonville 145
Shanghai 137
Nanjing 128
Dong Ket 111
Jakarta 53
Lawrence 49
Rome 46
Beijing 45
Nanchang 45
Altamura 41
Guangzhou 39
Falls Church 37
Lissone 37
Shenyang 37
Helsinki 35
London 35
San Diego 34
Fremont 32
Los Angeles 31
Hebei 29
Andover 28
Ottawa 26
Toronto 26
Changsha 23
Pune 23
Florence 22
Chicago 21
Jiaxing 21
Boardman 18
Cinisello Balsamo 18
Jinan 18
Lachine 18
Monza 18
Brussels 17
Pavia 17
Zhengzhou 17
Absecon 16
Caronno Pertusella 16
Norwalk 16
Brescia 15
Hangzhou 15
Ningbo 15
Tianjin 15
Madison 14
Montréal 14
Terni 14
Kunming 13
San Giuliano Milanese 13
Munich 12
Sesto San Giovanni 12
Cagliari 11
Centro Municipality 11
Edmonton 11
Lille 11
Bonndorf 10
Carate Brianza 10
Hefei 10
Kiev 10
Nuremberg 10
Padova 10
Washington 10
Fermignano 9
Melzo 9
Mountain View 9
Rho 9
Romola 9
Sacramento 9
Verona 9
Dallas 8
Naples 8
Napoli 8
Ripalta Cremasca 8
San Mateo 8
Birmingham 7
Brno 7
Daejeon 7
Guangdong 7
Legnano 7
Minamikasugaoka 7
Paullo 7
Salt Lake City 7
Totale 10.558
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 431
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 371
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 309
MALDI imaging in Fabry nephropathy: a multicenter study 302
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 278
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 272
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 271
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 268
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 267
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 266
3D bioprinted colorectal cancer models based on hyaluronic acid and signalling glycans 253
The proteomic landscape of renal tumors 252
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 249
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 241
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 240
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 239
The putative role of MALDI-MSI in the study of Membranous Nephropathy 237
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 235
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 234
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 229
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 228
Proteomics for the diagnosis of thyroid lesions: Preliminary report 217
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 215
Ion mobility mass spectrometry in the omics era: Challenges and opportunities for metabolomics and lipidomics 214
Proteomics for the study of new biomarkers in Fabry disease: State of the art 208
Tumor size, stage and grade alterations of urinary peptidome in RCC 205
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 205
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 199
Proteome analysis in thyroid pathology 198
MALDI-MSI in the study of glomerulonephritis: Possible molecular indicators of CKD progression 195
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 185
Thyreoglossal Duct Cyst with Evidence of Solid Cell Nests and Atypical Thyroid Follicles 172
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 171
MALDI-MSI analysis of cytological smears: The study of thyroid cancer 168
The impact of the non-invasive follicular thyroid neoplasm with papillary-like nuclear feature terminology in the routine diagnosis of thyroid tumours 168
Intraluminal proteome and peptidome of human urinary extracellular vesicles 163
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 162
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 161
The role of fine needle aspiration of orbital lesions: A case series 160
A molecular imaging approach to individuate tumour infiltrating lymphocytes 158
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 157
Incidental Papillary Thyroid Carcinoma: Diagnostic Findings in a Series of 287 Carcinomas 156
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 154
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 148
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 147
Machine learning approaches in MALDI-MSI: clinical applications 146
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 143
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 142
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 138
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 134
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 131
MALDI-MS imaging in the study of glomerulonephritis 129
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 126
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 122
The putative role of MALDI-MSI in the study of Membranous Nephropathy 113
MALDI-MSI analysis of lipid alterations in FFPE patient-derived breast cancer xenograft for pre-clinical and clinical application 110
The putative role of MALDI-MSI in the study of Membranous Nephropathy 108
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 107
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 99
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 97
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 97
α-1-antitrypsin detected by MALDI-Imaging in the study of glomerulonephritis: its relevance in chronic kidney disease progression 96
What’s brewing? Mapping the distribution of bioactive compounds in green C. arabica coffee beans through MS-driven spatial metabolomics 94
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 92
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 92
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 90
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 88
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 88
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 88
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 88
The Reed-Stanton press rig for the generation of reproducible fingermarks: Towards a standardised methodology for fingermark research 88
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 87
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 86
Determining the Age of a Latent Fingermark: Applying a Novel MALDI-MSI Methodology to an Age Old Forensic Conundrum 84
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 81
Molecular indicators of the progression of chronic kidney disease: a MALDI-Imaging approach in the study of glomerulonephritis 77
Reproducible lipid alterations in patient-derived breast cancer xenograft ffpe tissue identified with maldi msi for pre-clinical and clinical application 77
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 75
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 75
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 74
Towards obtaining molecular signatures of glomerulonephritis by MALDI-MSI: Preliminary evidence 73
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 73
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 72
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 71
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 70
Precision medicine for Diabetic Nephropathy and Hypertensive Nephrosclerosis 70
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 69
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 69
Sample preparation considerations in MALDI-MS Imaging: What is your goal? 66
Urinary peptide biomarker panel associated with an improvement in estimated glomerular filtration rate in chronic kidney disease patients 64
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 63
Correlazione di dati ottenuti con l’immagine istologica e microdissezione virtuale 63
MALDI mass spectrometry imaging in the analysis of primary glomerulonephritis 61
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 61
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 61
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 57
Towards obtaining molecular signatures of glomerulonephritis by MALDI-MSI: Preliminary evidence 57
Molecular indicators of the progression of chronic kidney disease: a MALDI-Imaging approach in the study of glomerulonephritis 55
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 52
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 47
Totale 14.794
Categoria #
all - tutte 53.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020721 0 0 0 0 0 0 0 168 178 149 169 57
2020/20212.332 98 111 244 290 219 233 191 256 154 169 124 243
2021/20221.490 119 143 91 162 114 145 39 83 60 113 149 272
2022/20232.574 298 692 241 199 101 393 47 200 171 37 113 82
2023/20242.134 75 84 82 145 196 584 436 52 132 36 82 230
2024/20252.256 224 449 344 213 437 183 310 96 0 0 0 0
Totale 15.293